Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
orosresearch.com
OROS Research holds a Disclosed Labs trust grade of A (92/100), computed independently from 44 lab Certificates of Analysis (as of July 2026). That's a strong, well-documented track record. Scores come only from lab COAs; vendors can't pay to raise them.
What is OROS Research's trust score?
OROS Research scores 92/100 (Grade A) on Disclosed Labs, from 44 lab COAs (as of July 2026).
How is OROS Research's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: July 7, 2026 · 100% pass rate
Composite score based on 44 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 44 COAs attributed to this vendor. Last recomputed 2026-07-07.
High-purity research peptides made in California. Your trusted source for 7-point tested, American-made peptides. Science without Shortcuts™. Founded in 2025.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | ARA-290/BPC-157/TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPREGEN40-526-B2 · Report 26EA0528-018 |
| Jun 3, 2026 | ARA-290 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPARA32-526-B1 · Report 26EA0528-019 |
| Jun 3, 2026 | AOD-9604 | HPLC purity | PASS | 99% | Ethos Analytics |
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="orosresearch"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/orosresearch.com" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> ✓ Verified by Disclosed Labs — independent COA trust score </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to OROS Research's live profile at https://www.disclosedlabs.com/vendors/orosresearch.com.
Links back to OROS Research's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| 5-Amino-1MQCOA ✓ | vial | 50mg | $74.99 | $1.50 | In stock | 2026-07-08 | View → |
| AOD-9604COA ✓ | vial | 5mg | $44.99 | $9.00 | In stock | 2026-07-08 | View → |
| ARA-290COA ✓ | vial | 32mg | $119.99 | $3.75 | In stock | 2026-07-08 | View → |
| BPC-157COA ✓ | vial | 5mg | $39.99 | $8.00 | In stock | 2026-07-08 | View → |
| BPC-157COA ✓ | vial | 10mg | $79.99 | $8.00 | In stock | 2026-07-08 | View → |
| BPC-157 + TB-500COA ✓ | blend | 10mg | $59.99 | $6.00 | In stock | 2026-07-08 | View → |
| BPC-157 + TB-500COA ✓ | blend | 20mg | $119.99 | $6.00 | In stock | 2026-07-08 | View → |
| Cartalax | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
| CJC-1295COA ✓ | vial | 5mg | $29.99 | $6.00 | In stock | 2026-07-08 | View → |
| DSIPCOA ✓ | vial | 5mg | $34.99 | $7.00 | In stock | 2026-07-08 | View → |
| EpitalonCOA ✓ | vial | 10mg | $34.99 | $3.50 | In stock | 2026-07-08 | View → |
| FOXO4-DRI | vial | 10mg | $199.99 | $20.00 | Sold out | 2026-07-08 | View → |
| GHK-Cu | vial | 50mg | $44.99 | $0.90 | In stock | 2026-07-08 | View → |
| GLOW Blend (GHK-Cu + BPC-157 + TB-500) | blend | 70mg | $109.99 | $1.57 | In stock | 2026-07-08 | View → |
| IpamorelinCOA ✓ | vial | 5mg | $34.99 | $7.00 | In stock | 2026-07-08 | View → |
| Kisspeptin-10 | vial | 5mg | $39.99 | $8.00 | In stock | 2026-07-08 | View → |
| KPVCOA ✓ | vial | 15mg | $74.99 | $5.00 | In stock | 2026-07-08 | View → |
| Melanotan IICOA ✓ | vial | 10mg | $29.99 | $3.00 | In stock | 2026-07-08 | View → |
| MOTS-cCOA ✓ | vial | 10mg | $49.99 | $5.00 | In stock | 2026-07-08 | View → |
| MOTS-cCOA ✓ | vial | 20mg | $99.99 | $5.00 | Sold out | 2026-07-08 | View → |
| NAD+ | vial | 500mg | $74.99 | $0.15 | In stock | 2026-07-08 | View → |
| Pinealon | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
| PT-141 | vial | 10mg | $39.99 | $4.00 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 5mg | $79.99 | $16.00 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 10mg | $139.99 | $14.00 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 20mg | $229.99 | $11.50 | In stock | 2026-07-08 | View → |
| SelankCOA ✓ | vial | 10mg | $44.99 | $4.50 | In stock | 2026-07-08 | View → |
| Semaglutide | vial | 5mg | $49.99 | $10.00 | In stock | 2026-07-08 | View → |
| SemaglutideCOA ✓ | vial | 10mg | $89.99 | $9.00 | In stock | 2026-07-08 | View → |
| SemaxCOA ✓ | vial | 30mg | $64.99 | $2.17 | In stock | 2026-07-08 | View → |
| SermorelinCOA ✓ | vial | 5mg | $44.99 | $9.00 | In stock | 2026-07-08 | View → |
| SS-31 | vial | 30mg | $109.99 | $3.67 | Sold out | 2026-07-08 | View → |
| TB-500 | vial | 5mg | $39.99 | $8.00 | In stock | 2026-07-08 | View → |
| TB-500COA ✓ | vial | 10mg | $64.99 | $6.50 | In stock | 2026-07-08 | View → |
| TesamorelinCOA ✓ | vial | 5mg | $44.99 | $9.00 | In stock | 2026-07-08 | View → |
| Tesamorelin | vial | 10mg | $89.99 | $9.00 | In stock | 2026-07-08 | View → |
| Testagen | vial | 20mg | $54.99 | $2.75 | In stock | 2026-07-08 | View → |
| Thymosin Alpha-1COA ✓ | vial | 5mg | $44.99 | $9.00 | In stock | 2026-07-08 | View → |
| TirzepatideCOA ✓ | vial | 10mg | $139.99 | $14.00 | In stock | 2026-07-08 | View → |
| Vasoactive Intestinal Peptide (VIP) | vial | 10mg | $59.99 | $6.00 | Sold out | 2026-07-08 | View → |
Prices are scraped from orosresearch.comand may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Full identity on file (0.03), Clean presence (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot OR-LPAOD5-326-B3 · Report 26EA0528-017 |
| Jun 3, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJCIPA10-526-B10 · Report 26EA0528-015 |
| Jun 3, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPCTB10-526-B5 · Report 26EA0528-020 |
| Jun 3, 2026 | SS-31/MOTS-c | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPSSMC20-526-B3 · Report 26EA0528-014 |
| Jun 1, 2026 | — | Identity & safety panels | PASS | -- | Ethos Analytics | Lot OR-SLBAC30-526-B3 · Report 26EA0528-016 |
| May 18, 2026 | N-Acetyl Semax Amidate | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPNASMX30-526-B2 · Report 26EA0515-043 |
| May 18, 2026 | 5-Amino-1MQ | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LP5A150-526-B1 · Report 26EA0515-040 |
| May 18, 2026 | N-Acetyl Selank Amidate | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPNASLK10-526-B2 · Report 26EA0515-044 |
| May 18, 2026 | Gut Matrix | Identity & safety panels | PASS | -- | Ethos Analytics | Lot OR-CGMTX201-526-B1 · Report 26EA0512-011 |
| May 18, 2026 | KLOW (GHK-Cu / BPC-157/ TB-500 / KPV) | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPKLO80-526-B4 · Report 26EA0512-007 |
| May 18, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJCIPA10-526-B9 · Report 26EA0512-010 |
| May 18, 2026 | Epithalon | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPEPI10-526-B2 · Report 26EA0515-039 |
| May 18, 2026 | CJC-1295 without DAC | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LP-CJCND5-526-B5 · Report 26EA0512-008 |
| May 18, 2026 | SS-31/MOTS-c | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPSSMC20-526-B2 · Report 26EA0512-009 |
| May 18, 2026 | Tesamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTES5-526-B6 · Report 26EA0515-038 |
| May 18, 2026 | BPC-157 Arginate | Identity & safety panels | PASS | -- | Ethos Analytics | Lot OR-CBPC500-526-B2 · Report 26EA0512-012 |
| May 18, 2026 | DSIP | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPDSP5-526-B2 · Report 26EA0515-041 |
| May 18, 2026 | BPC-157 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPC5-526-B5 · Report 26EA0515-042 |
| Apr 16, 2026 | BPC-157 / TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPCTB10-426-B4 · Report 26EA0410-037 |
| Apr 16, 2026 | KPV | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPKPV15-426-B2 · Report 26EA0410-027 |
| Apr 16, 2026 | CJC-1295 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJC5-426-B5 · Report 26EA0410-032 |
| Apr 16, 2026 | Semaglutide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPS10-426-B3 · Report 26EA0410-033 |
| Apr 16, 2026 | Melanotan-2 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPMT2-426-B5 · Report 26EA0410-030 |
| Apr 16, 2026 | Sermorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPSERM5-426-B4 · Report 26EA0410-036 |
| Apr 16, 2026 | Tesamorelin/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTESIPA20-426-B3 · Report 26EA0410-034 |
| Apr 16, 2026 | Tirzepatide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPT10-426-B3 · Report 26EA0410-029 |
| Apr 16, 2026 | Tirzepatide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPT5-426-B2 · Report 26EA0410-028 |
| Apr 16, 2026 | Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPIPA5-426-B4 · Report 26EA0410-031 |
| Apr 16, 2026 | MOTS-c | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPMOTS10-426-B7 · Report 26EA0410-035 |
| Apr 9, 2026 | Retatrutide | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPGLPR10-326-B2 · Report 26EA0403-010 |
| Apr 9, 2026 | TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTB10-326-B5 · Report 26EA0403-017 |
| Apr 9, 2026 | SS-31/MOTS-c | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPSSMC20-326-B1 · Report 26EA0403-021 |
| Apr 9, 2026 | Tesamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTES5-326-B5 · Report 26EA0403-020 |
| Apr 9, 2026 | Thymosin Alpha-1 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPTA5-326-B1 · Report 26EA0403-018 |
| Apr 9, 2026 | N-Acetyl Semax/N-Acetyl Selank | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPNASMSL15-326-B2 · Report 26EA0403-019 |
| Apr 9, 2026 | KLOW (GHK-Cu / BPC-157/ TB-500 / KPV) | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPKLO80-326-B3 · Report 26EA0403-022 |
| Apr 9, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJCIPA20-326-B2 · Report 26EA0403-012 |
| Apr 9, 2026 | CJC-1295/Ipamorelin | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPCJCIPA10-326-B8 · Report 26EA0403-011 |
| Apr 9, 2026 | BPC-157 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPC10-326-B5 · Report 26EA0403-016 |
| Apr 9, 2026 | Epithalon | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPEPI10-326-B2 · Report 26EA0403-015 |
| Apr 9, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPBPCTB20-326-B4 · Report 26EA0403-013 |
| Apr 9, 2026 | AOD-9604 | HPLC purity | PASS | 99% | Ethos Analytics | Lot OR-LPAOD5-326-B2 · Report 26EA0403-014 |
Disclosed Labs